Guest guest Posted June 12, 2006 Report Share Posted June 12, 2006 http://seattletimes.nwsource.com/text/2003051239_quickstudy11.html seattletimes.com Health Low-graphic news index Sunday, June 11, 2006 - Page updated at 12:00 a.m. Quick Study Update on major health topics By Linda Searing Special to The Washington Post HEART FAILURE Success at staving off disease may vary with medication type. THE QUESTION: High blood pressure often leads to heart failure, so treating hypertension is considered a prime means of prevention. Does it matter what type of blood-pressure drug is used? THIS STUDY analyzed medical data on 33,357 people who had participated in a study comparing antihypertensive drugs. Participants were at least 55 years old and had hypertension and at least one other risk factor for heart disease, such as being diabetic or a smoker. They had been randomly assigned to take a diuretic (chlorthalidone), a calcium channel blocker (amlodipine) or an ACE inhibitor (lisinopril). During a five-year period, 1,773 people were diagnosed with heart failure. During the first year after treatment, people who took a channel blocker or ACE inhibitor were more than twice as likely to have been hospitalized for heart failure or to have died from it as were those who took a diuretic. By the fifth year, those in the channel blocker group were 22 percent more likely than the others to have had serious heart failure. <<I thought the drugs were supposed to prevent the heart failure...looks like the drug companies want to sell more drugs. Notice the studies were funded by them>> WHO MAY BE AFFECTED BY THESE FINDINGS? People with high blood pressure. An estimated 90 percent of people with heart failure had high blood pressure first. CAVEATS: To control their blood pressure, most participants were given additional drugs as the study progressed; this may have affected the findings. The study was funded by Pfizer, which also provided medications, as did AstraZeneca and Bristol-Myers Squibb. Three of the 15 main authors had received fees from the companies. FIND THIS STUDY: May 9 issue of Circulation; abstract available online at www.circulationaha.org. " To be nobody-but-myself in a world which is doing its best, night and day, to make me everybody else - means to fight the hardest battle which any human being can fight, and never stop fighting. " -e.e. cummings- Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.